Abstract:Background: Molecular stratification and tailored target therapy bring clinical benefit for patients with triple-negative breast cancer (TNBC), but it is difficult to implement comprehensive molecular testing in clinical practice. Thus, we aim to devise an approach based on digital pathology and deep learning for the molecular and prognostic stratification of TNBC.Methods: We collected digital whole slide images (WSIs) (N=425) of our previously established TNBC cohort with multi-omics data. A deep learning-based workflow was developed and applied to these WSIs to train and validate neural network models to predict multi-omics molecular features, to identify molecular subtypes, and to improve prognostic evaluation. The models that showed high prediction accuracy were further validated on the TNBC cases from TCGA (N=143).Findings: A model was first developed for automatic tissue type classification, which enabled selection of certain tissue types on WSIs for the following prediction. Numerous molecular features can be inferred from WSIs including the somatic PIK3CA mutation, germline BRCA2 mutation and PD-L1 expression. All of the four molecular subtypes of TNBC can be accurately identified based on WSIs and distinctive morphological patterns were revealed for each subtype. The addition of image features to clinical prognostic factors significantly improved the accuracy of relapse risk assessment. The models for predicting PIK3CA mutation, PD-L1 expression, TNBC subtypes and relapse risk can be well generalized to the TCGA TNBC cases. The complete prediction workflow along with validated models was modularized and deployed on an online platform, which can realize real-time one-stop prediction for newly-uploaded WSIs.Interpretation: We proposed a deep learning-based workflow and developed neural network models to predict clinically relevant information of TNBC from pathological WSIs. Our findings and established platform may enable the implementation of artificial intelligence guided precision treatment in clinical trials and future routine practice.Funding: Fudan University Shanghai Cancer Center.Declaration of Interest: None to declare Ethical Approval: The tissue samples used in our study were obtained after the approval from the FUSCC Ethics Committee.

Deep Learning Insights into the Dynamic Effects of Photodynamic Therapy on Cancer Cells

Lonidamine Liposomes to Enhance Photodynamic and Photothermal Therapy of Hepatocellular Carcinoma by Inhibiting Glycolysis

Efficient evaluation of photodynamic therapy on tumor based on deep learning

Recent Advances in Photodynamic Therapy for Deep-Seated Tumors with the Aid of Nanomedicine

Programming DNA Nanoassembly for Enhanced Photodynamic Therapy

In Vivo Dynamic Monitoring of Circulating Melanoma Cells and the Inhibitory Effect of PD-L1 Inhibitor Based on PAFC Equipped with a Deep Learning Framework

Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy

Unveiling the Spatiotemporal and Dose Responses within a Single Live Cancer Cell to Photoswitchable Upconversion Nanoparticle Therapeutics Using Hybrid Hyperspectral Stimulated Raman Scattering and Transient Absorption Microscopy

Self-assembled peptide nanoparticles for photodynamic therapy: morphological and mechanical effects on hepatocellular carcinoma cells

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges

Deep Learning and Digital Pathology Power Precision Treatment of Triple-Negative Breast Cancer

Biology-guided deep learning predicts prognosis and cancer immunotherapy response

Photodynamic therapy upregulates expression of HIF-1α and PD-L1 in related pathways and its clinical relevance in non-small-cell lung cancer

Advances in smart nanotechnology-supported photodynamic therapy for cancer

Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death

Amplifying T cell‐mediated antitumor immune responses in nonsmall cell lung cancer through photodynamic therapy and anti‐PD1

Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer

Antitumor effects of a novel photosensitizer-mediated photodynamic therapy and its influence on the cell transcriptome

Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer

Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine

Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy